Clinical trial
INVEST: A Single Arm, Feasibility Study of Minimally Invasive Endoscopic Surgical Treatment With Apollo for Supratentorial Intracerebral Hemorrhage (ICH)
NCT02654015 is registered in ClinicalTrials.gov with J. Mocco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- INVEST: A Single Arm, Feasibility Study of Minimally Invasive Endoscopic Surgical Treatment With Apollo for Supratentorial Intracerebral Hemorrhage (ICH)
- Lead sponsor
- J. Mocco
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2017
- Completion date
- September 7, 2022
- Enrollment
- 50 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
intracranial hemorrhage